STUDY SEARCH RESULTS

375 studies found for your search request:  cancer

18F-FLT-PET in Breast Cancer (MK-0000-139)
Condition: Breast Cancer
Minimum Age: 35 years, Maximum Age: 75 years
Gender: Female
Study ID: NCT01015131
Status: Completed

A Clinical Study of Belzutifan (MK-6482) Alone or With Phenytoin in Healthy Participants (CA46602/MK...
Condition: Healthy
Minimum Age: 18 years, Maximum Age: 60 years
Gender: All
Study ID: NCT06903715
Status: Active, not recruiting

A Clinical Study of Boserolimab (MK-5890) with Pembrolizumab and Chemotherapy in People with Early T...
Condition: Early triple negative breast cancer
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT06829199
Status: Not yet recruiting

A clinical study of ifinatamab deruxtecan (I-DXd) in people with metastatic prostate cancer (MK-2400...
Condition: Prostate Cancer, Prostatic Neoplasms
Minimum Age: 18 years, Maximum Age: N/A
Gender: Male
Study ID: NCT06925737
Status: Recruiting
Has Enrolling Locations in US or Canada

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Me...
Condition: Castration-Resistant Prostatic Cancer, Metastasis
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT06863272
Status: Not yet recruiting




Copyright © 2025 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  Consumer Health Data Privacy Policy  Your Privacy Choices   Accessibility  U.S. Corporate Site